S. V. Luxemburg

Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment.

N. Weijl, E. Lentjes, A. Brand, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.